Hamilton Health Sciences is one of Canada's leading academic and research hospitals. The CALMA trial at HHS will be led by Dr. Alexandra Papaioannou, a distinguished geriatrician and Executive ...
POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...
IGC Pharma (IGC) announced that its ongoing Phase 2 trial for agitation in Alzheimer’s disease has been officially named CALMA. The trial’s new identity reflects its mission to address agitation, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results